{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:00:06Z","timestamp":1785769206374,"version":"3.56.0"},"reference-count":66,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2013,9,25]],"date-time":"2013-09-25T00:00:00Z","timestamp":1380067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurogastroenterology Motil"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Irritable bowel syndrome (<jats:styled-content style=\"fixed-case\">IBS<\/jats:styled-content>) impairs quality of life (<jats:styled-content style=\"fixed-case\">HRQOL<\/jats:styled-content>), as does systemic lupus erythematosus (<jats:styled-content style=\"fixed-case\">SLE<\/jats:styled-content>). Both are more common in women and are associated with fibromyalgia (<jats:styled-content style=\"fixed-case\">FM<\/jats:styled-content>). However, the relationship between <jats:styled-content style=\"fixed-case\">IBS<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">SLE<\/jats:styled-content> and its impact on <jats:styled-content style=\"fixed-case\">HRQOL<\/jats:styled-content> has not been explored. Therefore, we aimed to study the frequency and features likely to influence the presence of <jats:styled-content style=\"fixed-case\">IBS<\/jats:styled-content>\u2010type symptoms in <jats:styled-content style=\"fixed-case\">SLE<\/jats:styled-content> and their impact on <jats:styled-content style=\"fixed-case\">HRQOL<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Female patients with <jats:styled-content style=\"fixed-case\">SLE<\/jats:styled-content> were studied. The presence of <jats:styled-content style=\"fixed-case\">IBS<\/jats:styled-content>\u2010type symptoms and bowel habit subtype were established by Rome III criteria and <jats:styled-content style=\"fixed-case\">HRQOL<\/jats:styled-content> was assessed using the <jats:styled-content style=\"fixed-case\">SF<\/jats:styled-content>\u201036. Fibromyalgia and depression were assessed using the <jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>merican <jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>ollege of <jats:styled-content style=\"fixed-case\">R<\/jats:styled-content>heumatology criteria and <jats:styled-content style=\"fixed-case\">CES<\/jats:styled-content>\u2010D scale, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Key Results<\/jats:title><jats:p>A total of 105 consecutive patients (43.62\u00a0\u00b1\u00a011.34 years old) were included; 48.6% had <jats:styled-content style=\"fixed-case\">IBS<\/jats:styled-content>\u2010type symptoms (<jats:styled-content style=\"fixed-case\">SLE<\/jats:styled-content>+<jats:styled-content style=\"fixed-case\">IBS<\/jats:styled-content>) and were classified as <jats:styled-content style=\"fixed-case\">IBS<\/jats:styled-content>\u2010C: 23.5%, <jats:styled-content style=\"fixed-case\">IBS<\/jats:styled-content>\u2010D: 37.3%, and <jats:styled-content style=\"fixed-case\">IBS<\/jats:styled-content>\u2010M: 39.2%. In addition, 23.8% had <jats:styled-content style=\"fixed-case\">FM<\/jats:styled-content>. <jats:styled-content style=\"fixed-case\">SLE<\/jats:styled-content>+<jats:styled-content style=\"fixed-case\">IBS<\/jats:styled-content> vs Non\u2010<jats:styled-content style=\"fixed-case\">IBS SLE<\/jats:styled-content> patients had higher <jats:styled-content style=\"fixed-case\">SLE<\/jats:styled-content> activity scores (2.55\u00a0\u00b1\u00a01.65 vs 1.74\u00a0\u00b1\u00a02.19; p\u00a0=\u00a00.03), were more likely to have <jats:styled-content style=\"fixed-case\">FM<\/jats:styled-content> (33.0% vs 14.8%; p\u00a0=\u00a00.02) and depression (41.1% vs 25.9%, p\u00a0=\u00a00.04). Logistic multivariate analysis showed that <jats:styled-content style=\"fixed-case\">IBS<\/jats:styled-content>\u2010type symptoms were associated with <jats:styled-content style=\"fixed-case\">FM<\/jats:styled-content> (<jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>\u00a0=\u00a02.85, 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>: 1.11\u20137.43) and depression (<jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>\u00a0=\u00a01.07, 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>: 1.02\u20131.13). Finally, <jats:styled-content style=\"fixed-case\">SLE<\/jats:styled-content>+<jats:styled-content style=\"fixed-case\">IBS<\/jats:styled-content> vs Non\u2010<jats:styled-content style=\"fixed-case\">IBS SLE<\/jats:styled-content> patients had lower <jats:styled-content style=\"fixed-case\">SF<\/jats:styled-content>\u201036 scores (49.65\u00a0\u00b1\u00a018.57 vs 62.67\u00a0\u00b1\u00a018.14; p\u00a0=\u00a00.02).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions &amp; Inferences<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">IBS<\/jats:styled-content>\u2010type symptoms are highly prevalent among women with <jats:styled-content style=\"fixed-case\">SLE<\/jats:styled-content> and are associated with <jats:styled-content style=\"fixed-case\">FM<\/jats:styled-content> and depression. <jats:styled-content style=\"fixed-case\">SLE<\/jats:styled-content>+<jats:styled-content style=\"fixed-case\">IBS<\/jats:styled-content> patients had worse <jats:styled-content style=\"fixed-case\">HRQOL<\/jats:styled-content> vs Non\u2010<jats:styled-content style=\"fixed-case\">IBS SLE<\/jats:styled-content>, independently of <jats:styled-content style=\"fixed-case\">FM<\/jats:styled-content> status. We suggest that treating <jats:styled-content style=\"fixed-case\">IBS<\/jats:styled-content> symptoms may improve <jats:styled-content style=\"fixed-case\">HRQOL<\/jats:styled-content> in women with <jats:styled-content style=\"fixed-case\">SLE<\/jats:styled-content>.<\/jats:p><\/jats:sec>","DOI":"10.1111\/nmo.12230","type":"journal-article","created":{"date-parts":[[2013,10,11]],"date-time":"2013-10-11T22:23:29Z","timestamp":1381530209000},"page":"958-966","source":"Crossref","is-referenced-by-count":12,"title":["Irritable bowel syndrome\u2010type symptoms in female patients with mild systemic lupus erythematosus: frequency, related factors and quality of life"],"prefix":"10.1111","volume":"25","author":[{"given":"M.","family":"Garc\u00eda Carrasco","sequence":"first","affiliation":[{"name":"Systemic Autoimmune Diseases Research Unit Hospital General Regional No. 36, Instituto Mexicano del Seguro Social Puebla Puebla M\u00e9xico"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica de Oriente Instituto Mexicano del Seguro Social Metepec Puebla M\u00e9xico"},{"name":"Immunology and Rheumatology Medicine School, Benem\u00e9rita Universidad Aut\u00f3noma de Puebla Puebla Puebla M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Mendoza Pinto","sequence":"additional","affiliation":[{"name":"Systemic Autoimmune Diseases Research Unit Hospital General Regional No. 36, Instituto Mexicano del Seguro Social Puebla Puebla M\u00e9xico"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica de Oriente Instituto Mexicano del Seguro Social Metepec Puebla M\u00e9xico"},{"name":"Immunology and Rheumatology Medicine School, Benem\u00e9rita Universidad Aut\u00f3noma de Puebla Puebla Puebla M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"L\u00f3pez Colombo","sequence":"additional","affiliation":[{"name":"Puebla Research Coordination Instituto Mexicano de Seguro Social Puebla Puebla M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"M\u00e9ndez Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Systemic Autoimmune Diseases Research Unit Hospital General Regional No. 36, Instituto Mexicano del Seguro Social Puebla Puebla M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Andari Sawaya","sequence":"additional","affiliation":[{"name":"Medicine Department Temple University Hospital Philadelphia PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Mu\u00f1oz Guarneros","sequence":"additional","affiliation":[{"name":"Research and Postgraduate Department Medicine School Ben\u00e9merita Universidad Aut\u00f3noma de Puebla Puebla Puebla Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"V\u00e1zquez De Lara","sequence":"additional","affiliation":[{"name":"Research and Postgraduate Department Medicine School Ben\u00e9merita Universidad Aut\u00f3noma de Puebla Puebla Puebla Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lescas Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Systemic Autoimmune Diseases Research Unit Hospital General Regional No. 36, Instituto Mexicano del Seguro Social Puebla Puebla M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Montiel Jarqu\u00edn","sequence":"additional","affiliation":[{"name":"Direction of Education and Research Hospital General Regional No 36, Instituto Mexicano del Seguro Social Puebla Puebla M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Ramos \u00c1lvarez","sequence":"additional","affiliation":[{"name":"Systemic Autoimmune Diseases Research Unit Hospital General Regional No. 36, Instituto Mexicano del Seguro Social Puebla Puebla M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Schmulson","sequence":"additional","affiliation":[{"name":"Laboratory of Liver Pancreas and Motility (HIPAM)\u2010Department of Experimental Medicine Faculty of Medicine\u2010Universidad Nacional Aut\u00f3noma de M\u00e9xico (UNAM) M\u00e9xico City M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,9,25]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.11.061"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.02.029"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02036.x"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.5056\/jnm.2011.17.4.349"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.427"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.32978"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200624010-00002"},{"issue":"2","key":"e_1_2_10_9_1","first-page":"S3","article-title":"Impact of irritable bowel syndrome: prevalence and effect on health\u2010related quality of life","volume":"3","author":"El\u2010Serag HB","year":"2003","journal-title":"Rev Gastroenterol Discord"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02183.x"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2000.16484"},{"key":"e_1_2_10_12_1","first-page":"1061","article-title":"Mortality studies in systemic lupus erythematosus: results from a single center. III. Improved survival over 24\u00a0years","volume":"24","author":"Urowitz MB","year":"1997","journal-title":"J Rheumatol"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/0961203306071710"},{"key":"e_1_2_10_14_1","first-page":"207","article-title":"Quality of life in systemic lupus erythematosus patients in Northeastern Brazil: is health related quality of life a predictor of survival for these patients?","volume":"34","author":"Freire E","year":"2009","journal-title":"Acta Reumatol Port"},{"key":"e_1_2_10_15_1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.47102\/annals-acadmedsg.V36N2p115","article-title":"Health\u2010related quality of life in patients with systemic lupus erythematosus: an update","volume":"36","author":"Thumboo J","year":"2007","journal-title":"Ann Acad Med Singapore"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1964.03070150014003"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.32392"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2006.04.002"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.01643.x"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-006-0037-z"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0b013e31823ae69e"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.01977.x"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.159"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0049-0172(80)90016-5"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.45.0136"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.46.0137"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.61.6.547"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1177\/0961203307082383"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400928"},{"key":"e_1_2_10_30_1","first-page":"1551","article-title":"Measurement of disease activity in systemic lupus erythematosus. Prospective validation of 3 clinical indices","volume":"19","author":"Guzman J","year":"1992","journal-title":"J Rheumatol"},{"key":"e_1_2_10_31_1","first-page":"373","article-title":"The Systemic Lupus International Collaborating Clinics\/American College of Rheumatology (SLICC\/ACR) Damage Index for systemic lupus erythematosus international comparison","volume":"27","author":"Gladman DD","year":"2000","journal-title":"J Rheumatol"},{"key":"e_1_2_10_32_1","first-page":"S386","article-title":"Multinational validation of the Spanish ROME III adult diagnostic questionnaire: comparable sensitivity and specificity to English instrument","volume":"138","author":"Morgan DR","year":"2012","journal-title":"Gastroenterology"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780330203"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1177\/014662167700100306"},{"key":"e_1_2_10_35_1","first-page":"110","article-title":"Evaluation of health status using survey SF\u201036: preliminary results in Mexico","volume":"41","author":"Z\u00faniga MA","year":"1999","journal-title":"Salud Publica Mex"},{"key":"e_1_2_10_36_1","first-page":"1608","article-title":"Consistency and validity of patient administered assessment of quality of life by the MOS SF\u201036; its association with disease activity and damage in patients with systemic lupus erythematosus","volume":"24","author":"Stoll T","year":"1997","journal-title":"J Rheumatol"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v10.i7.1059"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/606174"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(12)63220-X"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1159\/000092887"},{"key":"e_1_2_10_41_1","first-page":"125","article-title":"The brain\u2010gut axis in irritable bowel syndrome\u2010clinical aspects","volume":"10","author":"Mach T","year":"2004","journal-title":"Med Sci Monit"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.120"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.5056\/jnm.2010.16.4.363"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2008.94"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2008.01220.x"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1080\/00365520802272126"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1080\/00365520701396216"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.5056\/jnm.2012.18.1.78"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.12.015"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.30282"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365528909093089"},{"key":"e_1_2_10_52_1","first-page":"S305","article-title":"Small intestinal bacterial overgrowth in systemic lupus erythematosus","volume":"42","author":"Albano S","year":"1999","journal-title":"Arthritis Rheum"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1177\/0961203306075739"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02258235"},{"key":"e_1_2_10_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01300088"},{"key":"e_1_2_10_56_1","first-page":"S22","article-title":"Association between fibromyalgia and psychiatric disorders in systemic lupus erythematosus","volume":"28","author":"Torrente\u2010Segarra V","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_10_57_1","doi-asserted-by":"publisher","DOI":"10.1191\/0961203304lu480oa"},{"key":"e_1_2_10_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23828"},{"key":"e_1_2_10_59_1","first-page":"584573","article-title":"The prevalence of fibromyalgia in other chronic pain conditions","volume":"2012","author":"Yunus MB","year":"2012","journal-title":"Pain Res Treat"},{"key":"e_1_2_10_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.33339"},{"key":"e_1_2_10_61_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2849-07.2007"},{"key":"e_1_2_10_62_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.psy.0000146329.63158.40"},{"key":"e_1_2_10_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.janxdis.2008.08.004"},{"key":"e_1_2_10_64_1","first-page":"1706","article-title":"How does quality of life of patients with systemic lupus erythematosus compare with that of other common chronic illnesses?","volume":"32","author":"Jolly M","year":"2005","journal-title":"J Rheumatol"},{"key":"e_1_2_10_65_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.psy.0000204897.25745.7c"},{"key":"e_1_2_10_66_1","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e31821fbf44"},{"key":"e_1_2_10_67_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23339"}],"container-title":["Neurogastroenterology &amp; Motility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fnmo.12230","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/nmo.12230","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T22:13:42Z","timestamp":1696284822000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/nmo.12230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,25]]},"references-count":66,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["10.1111\/nmo.12230"],"URL":"https:\/\/doi.org\/10.1111\/nmo.12230","archive":["Portico"],"relation":{},"ISSN":["1350-1925","1365-2982"],"issn-type":[{"value":"1350-1925","type":"print"},{"value":"1365-2982","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,25]]}}}